← Open Payments lookup

CHAU TON-THAT: Open Payments

NPI 1205902301 · WESTMINSTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,737 in 72 payments from 9 companies in 2025. Trend: 2023 $2,568 · 2024 $1,408 · 2025 $1,737

Food & beverage: $1,737
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$467
Vanda Pharmaceuticals Inc.14$438
Alkermes, Inc.18$333
E.R. Squibb & Sons, L.L.C.9$201
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$155
Axsome Therapeutics, Inc.2$52
Lundbeck LLC1$32
LivaNova USA, Inc.1$31
Neurocrine BioSciences, Inc.1$28

Products named: HETLIOZ, ARISTADA, REXULTI, COBENFY, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, FANAPT.

Industry payments across CA — which companies pay providers there.